Allogeneic hematopoietic transplantation following reduced-intensity-conditioning with 200cGy TBI and Fludarabine in MDS

被引：0
|
作者：
Al-Ali, H. K. [1 ]
Jaekel, N. [1 ]
Nehring, C. [1 ]
Krahl, R. [1 ]
Becker, C. [1 ]
Braunert, L. [1 ]
Leiblein, S. [1 ]
Franke, G. [1 ]
Lange, T. [1 ]
Niederwieser, D. [1 ]
机构：
[1] Univ Leipzig, Leipzig, Germany
来源：
ONKOLOGIE | 2011年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：301 / 301
页数：1
相关论文
共 50 条
  • [31] Severe fludarabine neurotoxicity after reduced intensity conditioning regimen to allogeneic hematopoietic stem cell transplantation: a case report
    Annaloro, Claudio
    Costa, Antonella
    Fracchiolla, Nicola S.
    Mometto, Gabriella
    Artuso, Silvia
    Saporiti, Giorgia
    Tagliaferri, Elena
    Grifoni, Federica
    Onida, Francesco
    Cortelezzi, Agostino
    CLINICAL CASE REPORTS, 2015, 3 (07): : 650 - 655
  • [32] Impact of low-dose TBI on outcomes of reduced intensity conditioning allogeneic hematopoietic stem cell transplantation for AML
    J Aoki
    S Seo
    H Kanamori
    M Tanaka
    T Fukuda
    M Onizuka
    N Kobayashi
    T Kondo
    M Sawa
    N Uchida
    K Iwato
    T Icihnohe
    Y Atsuta
    S Yano
    A Takami
    Bone Marrow Transplantation, 2016, 51 : 604 - 606
  • [33] Impact of low-dose TBI on outcomes of reduced intensity conditioning allogeneic hematopoietic stem cell transplantation for AML
    Aoki, J.
    Seo, S.
    Kanamori, H.
    Tanaka, M.
    Fukuda, T.
    Onizuka, M.
    Kobayashi, N.
    Kondo, T.
    Sawa, M.
    Uchida, N.
    Iwato, K.
    Icihnohe, T.
    Atsuta, Y.
    Yano, S.
    Takami, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 (04) : 604 - 606
  • [34] Fludarabine is superior to cladribine when added to Busulfan and low dose TBI as reduced intensity conditioning for allogeneic hematopoietic cell transplantation (HCT): A prospective randomized trial.
    Markova, M
    Barker, JN
    Wagner, JE
    Miller, JS
    Arora, M
    Burns, LJ
    MacMillan, ML
    Repka, T
    Blazar, BR
    Weisdorf, DJ
    BLOOD, 2004, 104 (11) : 505A - 505A
  • [35] Reduced intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma.
    Majolino, I
    Arana, MG
    Riccardi, M
    Locasciulli, A
    Bacigalupo, A
    Di Bartolomeo, P
    Scimè, R
    Olivieri, A
    Narni, F
    De Fabritiis, P
    Corradini, P
    BLOOD, 2003, 102 (11) : 465B - 465B
  • [36] Reduced intensity conditioning for allogeneic transplantation
    Foss, FM
    ANNALS OF ONCOLOGY, 2005, 16 : 258 - 258
  • [37] Reduced-intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma
    Majolino, I
    Arana, MG
    Riccardi, M
    Locasciulli, A
    Bacigalupo, A
    Di Bartolomeo, P
    Scimè, R
    Olivieri, A
    Narni, F
    De Fabritiis, P
    Corradini, P
    BONE MARROW TRANSPLANTATION, 2004, 33 : S37 - S38
  • [38] Reduced-intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma
    Majolino, I
    Carnevalli, E
    Locasciulli, A
    Di Bartolomeo, P
    Scimè, R
    Corradini, P
    Selleri, M
    Narni, F
    Musso, M
    Bregni, M
    Olivieri, A
    De Fabritiis, P
    Pogliani, L
    Ruscio, C
    Bacigalupo, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S144 - S145
  • [39] Allogeneic hematopoietic cell transplantation (HCT) following reduced-intensity conditioning in patients with acute leukemias
    Niederwieser, D
    Gentilini, C
    Hegenbart, U
    Lange, T
    Becker, C
    Wang, SY
    Bartsch, K
    Pönisch, W
    Raida, M
    Al-Ali, H
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 56 (02) : 275 - 281
  • [40] Retrospective comparison of hematopoietic stem cell transplantation following reduced-intensity conditioning with fludarabine/low-dose melphalan plus 4 Gy TBI versus fludarabine/busulfan plus 4 Gy TBI
    Yamada, Yuta
    Ikegawa, Shuntaro
    Najima, Yuho
    Atsuta, Yuya
    Konuma, Ryosuke
    Adachi, Hiroto
    Wada, Atsushi
    Kishida, Yuya
    Konishi, Tatsuya
    Nagata, Akihito
    Kaito, Satoshi
    Nagata, Ryohei
    Noguchi, Yuma
    Marumo, Atsushi
    Mukae, Junichi
    Inamoto, Kyoko
    Toya, Takashi
    Igarashi, Aiko
    Kobayashi, Takeshi
    Sakamaki, Hisashi
    Ohashi, Kazuteru
    Doki, Noriko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (02) : 244 - 254
12345